Arti Bhelekar

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer

Vijay Patil, Vanita Noronha, Amit Joshi et al. · Cancer · 2019 · 130 citations

Medicine, Oncology, Radiation Oncology +11

Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial

Vijay Patil, Vanita Noronha, Sachin Dhumal et al. · The Lancet Global Health · 2020 · 102 citations · Full text

Medicine, Oncology, Chemotherapy +11

Reverse swing‐M, phase 1 study of repurposing mebendazole in recurrent high‐grade glioma

Vijay Patil, Arti Bhelekar, Nandini Menon et al. · Cancer Medicine · 2020 · 24 citations · Full text

Medicine, Oncology, Pharmacology +16

Results of a randomized phase III study of nimotuzumab in combination with concurrent radiotherapy and cisplatin versus radiotherapy and cisplatin alone, in locally advanced squamous cell carcinoma of the head and neck.

Vijay Patil, Vanita Noronha, Amit Joshi et al. · Journal of Clinical Oncology · 2018 · 11 citations

Medicine, Oncology, Radiation Oncology +6